Unbiased balanced decision making.

Broader interpretation of the available diagnostic information.

Ability to implement evidence-based, guideline-directed therapy.

Clear documentation and improved governance.

Better allocation of limited resources.

Consideration of novel therapies.

Risk of bias depending on team member attendance.

Lack of consistent terms of reference.

Time delay from referral to treatment decision.

Lack of administrative support.

Lack of consistency worldwide.

Lack of supportive evidence for the benefit.

Lack of familiarity of the patient at the centre of discussion.